Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Fallopian Tube Neoplasms 2Carcinoma, Ovarian Epithelial 2Small Cell Lung Carcinoma 1Sarcoma 1Neurofibrosarcoma 1Neoplasms 1Lung Cancer - Malignant Pleural Mesothelioma 1Leukemia, Myeloid, Acute 1Leukemia 1Disorders of Sex Development 1

Interventions

pazopanib 3pembrolizumab 2Sirolimus 2temsirolimus 1selinexor 1sapanisertib 1pexidartinib 1liposomal doxorubicin 1lentiviral minigene vaccine of COVID-19 coronavirus 1STA 9090 1Proton Therapy 1Imatinib Mesylate 1Ifosfamide 1HhAntag691 1Doxorubicin 1Docetaxel 1AZD 6244 12,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Neurofibrosarcoma × STA 9090 × Clear all
NCT02008877 2019-05-15

SARC023: Ganetespib and Sirolimus in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors)

Sarcoma Alliance for Research through Collaboration

Phase 1/2 Completed
20 enrolled 20 charts
Sarcoma

Sarcoma, Neurofibrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡